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ARTICLE IN PRESSSchizophrenia ResearchLetter to the EditorSchizophrenia aetiology: Do gene-environment
interactions hold the key? Comment on Tandon et al.1. Heritability is more than genetic main effects
Tandon and colleagues point out that while no gene-
tic variation has been consistently associated with schi-
zophrenia, there is more consistent evidence implicating
a range of environmental factors. The authors cite he-
ritability estimates in schizophrenia of around 80%, and
interpret these as indicating that 80% of the liability to
schizophrenia is genetic. Heritability estimates, how-
ever, are derived from genetic epidemiological studies
that estimate simple genetic and simple environmental
contributions to schizophrenia liability; unfortunately,
these do not model the contribution of gene-environ-
ment interactions (G×E), because researchers tend to
not include direct measures of the environment in such
studies, thus precluding the quantification of gene-
environment interactions. Therefore, the heritability of
schizophrenia may be 80%, but simulations show that
gene-environment interactions may make up the bulk of
this proportion (Van Os and Sham, 2003). While many
thousands of studies have focused on the interpretation
of heritability as indicating pure genetic effects, a small
but growing number of studies have attempted to mea-
sure both genes and environments and conduct gene-
environment interaction analyses.
2. Gene-environment interaction studies
Gene-environment interaction studies can be power-
ful, as they do not necessarily rely on direct molecular
measures of genetic variation (Murray et al., 1986).
Instead, they can model genetic contributions using a
range of genetically sensitive adoption, twin or family
designs, or use intermediate biological phenotypes
previously linked to genetic risk (Van Os and Marcelis,
1998). Although Tandon and colleagues do not review0920-9964/$ - see front matter © 2008 Elsevier B.V. All rights reserved.
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consistent, albeit preliminary, evidence for G×E from a
range of studies using indirect measures of genetic risk,
including, for example, four replications of gene-
urbanicity interaction (review by van Os and Poulton,
2008). These important early findings are now being
extended to studies using direct molecular genetic
measures of genetic variation in schizophrenia and re-
lated mental disorders (Caspi et al., 2005; Nicodemus
et al., in press; Stefanis et al., 2007). Given these
promising developments, there is an urgent need for
well-conducted, large-scale G×E studies.
3. Challenges facing G×E studies
Systematic attempts to identify gene-environment
interaction cannot be equated with traditional molecular
genetic studies with a few putative environmental var-
iables thrown in. The study of G×E is amultidisciplinary
exercise involving epidemiology, psychology, psychia-
try, neuroimaging, pharmacology, biostatistics and gene-
tics. The challenges to overcome in the years to come are
numerous and will be briefly outlined here.
3.1. The environment
First, it is extremely difficult to measure and model
environmental effects (Jones and Cannon, 1998). Epi-
demiological studies of environmental risks are prone to
bias, confounding and reverse causality, and the genetic
liability to schizophrenia may increase the risk of
exposure to certain environments (genetic control of
exposure to the environment) rather than bemoderated by
them (genetic control of sensitivity to the environment)
(Collip et al., in press). Therefore, observational studies
on environmental effects need to be complemented by
experimental studies using placebo-controlled random
assignment to environmental exposures which, in combi-
nation with genotyping, allow for experimental ecoge-
netic approaches (Henquet et al., 2006). The advent offor the Study of Gene-Environment Interactions (EU-GEI), Schizophrenia
n et al., Schizophor. Res. (2008), doi:10.1016/j.schres.2008.04.003
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may similarly represent an important asset for the study of
environmental exposures (Freeman et al., 2003). Second,
the environment can be conceptualized atmany levels that
may all be relevant to behavioural phenotypes associated
with schizophrenia, varying from minor stressors in the
flow of daily life as assessed by momentary assessment
technologies (Myin-Germeys et al., 2001), to contextual
effects of the wider social environment such as neigh-
bourhoods or ethnic density (Boydell et al., 2001;
Kirkbride et al., 2007). Third, some environmental risks
such as “urbanicity” and “ethnicity” are proxies for as yet
unidentified environmental or possibly even genetic
factors (Pedersen and Mortensen, 2006; Selten et al.,
2007). Fourth, “functional enviromics”, or the study of the
mechanisms underlying environmental impact on the
individual to increase the risk for psychopathology is still
in its infant stages, with many hypotheses that remain to
be tested. These include effects of the environment on (i)
developmental programming and adult functional circuits
of the brain, (ii) neuroendocrine and neurotransmitter
functioning, (iii) patterns of interpersonal interactions that
may shape risk for later psychopathology and (iv)
affective and cognitive processing (Rutter, 2005). Con-
versely, hypotheses need to be tested about the neural
mechanism by which genetic variation may increase
susceptibility to environmental stressors. These mechan-
isms and their underlying pathophysiological pathways
need to be clarified in order to develop a priori gene-
environment interaction research paradigms. For exam-
ple, is has been suggested that there may be synergistic
effects of genes and environment in bringing about a
“sensitization” (Featherstone et al., 2007) (Tenn et al.,
2005) ofmesolimbic dopamine neurotransmission (Collip
et al., in press; Howes et al., 2004). This hypothesis is
supported by (i) evidence quantifying the impact of stress
and dopamine agonist drugs on mesolimbic dopamine
release and subsequent sensitization (Arnsten and Gold-
man Rakic, 1998; Boileau et al., 2006; Covington and
Miczek, 2001) as well as stress-dopamine agonist cross-
sensitisation (Hamamura and Fibiger, 1993; Nikulina et
al., 2004; Yui et al., 2000) and (ii) evidence indicating that
genetic risk for schizophrenia is associated with under-
lying alterations in the dopamine system, including
increased dopamine synaptic availability (Hirvonen et
al., 2005), increased striatal dopamine synthesis (Huttu-
nen et al., 2008; Meyer-Lindenberg et al., 2002) and
increased dopamine reactivity to stress (Brunelin et al.,
2008; Myin-Germeys et al., 2005). Thus, a case can be
made for investigating genetic variation affecting dopa-
mine neurotransmission in interactionwith environmental
risk factors such as stress and dopamine agonist drugs.Please cite this article as: The EuropeanNetwork of Schizophrenia Networks
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focussing on genes associated with dopamine neurotrans-
mission suggest that this gene group may be useful for
G×E studies. For example, a recent large study focussing
on gene-gene interaction (epistasis) and functional effects
suggested that a network of interacting dopaminergic
polymorphisms may increase risk for schizophrenia
(Talkowski et al., 2008). Evidence for epistasis between
genes impacting on dopamine signalling can be validated
using a neural systems-level intermediate phenotype
approach in humans. Recent work of this type, using a
prefrontal function fMRI phenotype, similarly suggests
epistasis between polymorphisms in genes that control
dopamine signalling (Buckholtz et al., 2007; Meyer-
Lindenberg et al., 2006). More specifically, there is
evidence that schizophrenia may be characterised by a
combination of prefrontal cortical dysfunction and sub-
cortical dopaminergic disinhibition (Meyer-Lindenberg
et al., 2002). Research has shown that the valine-allele
carriers of a functional polymorphism in the catechol-O-
methyltransferase gene (COMTVal158Met), an important
enzyme regulating prefrontal dopamine turnover, pre-
dicted increased dopamine synthesis in the midbrain,
suggesting that this allele may increase the risk for
schizophrenia in interaction with, for example, stress and
dopamine agonist drugs (Meyer-Lindenberg et al., 2005).
Several studies suggest that valine-allele carriers may
indeed be more sensitive to the psychotogenic effects of
drugs of abuse or stress (Caspi et al., 2005; Henquet et al.,
2006; Stefanis et al., 2007).
3.2. Genes
Traditional genetic approaches in schizophrenia are
increasingly challenged by new insights into the com-
plexities of genomic architecture and genetic regulation
(Pearson, 2006). For example, deletions, insertions, du-
plications and complex multi-site variants, referred to as
copy number variations (CNVs), are found in all hu-
mans, are functionally significant and likely of con-
siderable contribution to phenotypic variation (Redon
et al., 2006). Indeed, there is recent evidence impli-
cating CNVs in the aetiology of some cases of schi-
zophrenia (Kirov et al., 2008; Walsh et al., in press) as
well as evidence going back some years that deletions of
22q11 are associated with greatly increased risk of the
disorder (Murphy et al., 1999). In addition, there is
evidence that protein-coding exons from one part of the
genome combine with exons from another part that
can be hundreds of thousands of bases away, with se-
veral other ‘genes’ in between or even spilling over the
boundaries of chromosomes, creating a continuum offor the Study of Gene-Environment Interactions (EU-GEI), Schizophrenia
n et al., Schizophor. Res. (2008), doi:10.1016/j.schres.2008.04.003
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factured by the human genome do not code for proteins
but are actively processing and carrying out instructions in
the genome, complicating traditional models of in-
heritance. Of particular interest to the theme of G×E
is the fact that environmental factors in schizophrenia
may induce epigenetic changes resulting from promoter
DNA methylation affecting gene expression in neural
systems relevant for psychotic disorder. It has been argued
that in particular the dopaminergic system may constitute
a promising target for epigenetic study in the area of G×E
(Abdolmaleky et al., 2008). The central reversible epi-
genetic modification to DNA is brought about by me-
thylation of the cytosine residues that may be heritable
and can alter gene expression and processes downstream
thereof. These changes may interact with genetic vul-
nerability associated with genetic sequence variation. The
consequence for the concept of gene-environment inter-
action is that one can envisage a process of environmen-
t × epigenetic ×genetic interaction in schizophrenia
(Fig. 1). For example, there is strong evidence from ani-
mal research that the prenatal and early postnatal psy-
chosocial environment affects gene expression impacting
on adult neurobiological systems implicated in psychiatric
disorders (Jirtle and Skinner, 2007; Meaney and Szyf,
2005). These findings may shed light on the mechanism
of similar prenatal and postnatal risk factors for schizo-
phrenia such as replicated evidence of the effect of
prenatal stress (Huttunen and Niskanen, 1978; Khashan
et al., 2008; Van Os and Selten, 1998) and the possible
association between early life stress and later psychoticFig. 1. Complexity of gene-en
Please cite this article as: The EuropeanNetwork of Schizophrenia Networks
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research has shown that early life stress affects adult
environmental reactivity of the dopamine system (Hall
et al., 1999) which may be mediated by epigenetic
changes (Moffett et al., 2007). A recent human study
reported that mesolimbic dopamine release in response to
psychosocial stress depended on low early life maternal
care (Pruessner et al., 2004). Thus, early environmental
stressors may be associated with differential promoter
DNA methylation patterns creating vulnerabilities for
later environmental exposures, possibly in interaction
with differential genetic sequence variation as discussed
above. A comprehensive investigation of differential me-
thylation-mediated epigenetic alterations, induced by
environmental exposures is called for; a case for a plau-
sible hypothesis-driven approach can be made for certain
gene families and systems.
3.3. Phenotypes
The question implied by Tandon and colleagues is
to what degree the changing DSM concepts of schi-
zophrenia are helping rather than hampering research into
the aetiology and epidemiology of schizophrenia (Al-
lardyce et al., 2007). The study of molecular genetics
and gene-environment interactions will likely catalyze
a reappraisal of psychiatric nosology (Owen et al., 2007)
and in order to elucidate converging pathways that are
the site of biological synergism between genes and
environments, a wide range of approaches employing
intermediate (or endo-) phenotypes are necessary in, forvironment interactions.
for the Study of Gene-Environment Interactions (EU-GEI), Schizophrenia
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phenotypes (Barkus et al., 2007; Meyer-Lindenberg et al.,
2006; Murray et al., 2008), cognition (Barnett et al.,
2007a; Barnett et al., 2007b; Bombin et al., in press;
Filbey et al., in press; Toulopoulou et al., 2007), neu-
roanatomy (Boos et al., 2007; Marcelis et al., 2003; van
Haren et al., 2008), salience attribution (Jensen et al.,
2008; Kapur, 2003), treatment response (Arranz and de
Leon, 2007),measures of course and outcome (Verdoux et
al., 1996), subclinical psychosis expression (Schurhoff et
al., 2007; Schurhoff et al., 2003; Stefanis et al., 2004),
neurotic symptoms (Zinkstok et al., 2008) and dynamic
cerebral phenotypes in early onset groups (Arango et al.,
2008).
3.4. Biostatistics
It is likely that mass genome-wide molecular genetic
approaches, “enriched” with a few measures of
“environmental” exposures will create invalid and
confusing findings, largely because of the extent of
multiple testing and the opportunities for post-hoc
analyses afforded by such studies. It is of paramount
importance to consider the study of G×E as a separate
discipline, requiring a highly specialised and multi-
disciplinary approach taking both environment and
genes seriously. A hypothesis-driven strategy focussing
on pathways at which biological synergism between
genetic and environmental mechanisms may take place,
fed by information from functional enviromics and
functional genomics pointing to promising neural
systems and processes may constitute the most produc-
tive approach. In combination, this should enable a
translational approach to systematically study the effect
of environmental manipulations on neural systems
linked to genetic risk for schizophrenia. However,
even a hypothesis-driven approach is likely to face
major challenges in the area of biostatistics. Even
allowing for the major problem of how to bridge the gap
between statistical interaction (statistical manipulations
of data) and biological synergism (biological processes
in nature), which currently cannot be estimated directly
(Van Os and Sham, 2003), solutions to, for example,
modelling multiple ambiguous haplotype×environment
interactions need to be developed further (Lake et al.,
2003) and methods to increase power in G×E studies
are urgently required (Boks et al., 2007).
4. Conclusion
In conclusion, the review by Tandon and colleagues
is comprehensive and timely. Far from being a theo-Please cite this article as: The EuropeanNetwork of Schizophrenia Networks
aetiology: Do gene-environment interactions hold the key? Comment on Tandoretical afterthought, the study of G×E now deserves
center stage and multidisciplinary action, given the fact
that a multitude of findings point to biological sy-
nergism that can now be elucidated given the right
hypothesis-driven approach.
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